Gene delivery strategies for cartilage tissue engineering

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Gene Therapy

Background:

• Cartilage regeneration remains a significant challenge in tissue engineering.
• Current strategies often focus on controlled release of growth factors.
• An alternative approach involves engineering cells for sustained protein production via gene delivery.

Purpose of the Study:

• To explore the potential of gene therapy as a strategy for cartilage regeneration.
• To review existing knowledge on cell types, vectors, and genes used in articular disease gene therapy.
• To investigate the combination of gene therapy techniques with tissue engineering for simultaneous cartilage repair.

Main Methods:

• Review of gene therapy studies for articular diseases (rheumatoid arthritis, osteoarthritis).
• Analysis of different cell types, gene delivery vectors (viral and non-viral), and therapeutic genes.
• Exploration of combining gene transfer techniques within tissue engineering frameworks.

Main Results:

• Gene therapy offers a method to convert cells into protein-producing factories for cartilage regeneration.
• Non-viral gene delivery vectors are increasingly favored over viral vectors.
• The choice of cell, vector, and gene significantly impacts the resulting cartilage properties.

Conclusions:

• Integrating gene therapy into tissue engineering presents a promising, albeit novel, approach for cartilage repair.
• Further research is crucial to understand the interplay between cellular components, vectors, and genes in determining cartilage quality.
• Optimizing these factors is essential for successful physiological and biomechanical outcomes in engineered cartilage.